Trexquant Investment LP Axonics, Inc. Transaction History

Trexquant Investment LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$47.99 - $60.21 $166,717 - $209,169	-3,474 Reduced 7.37%	43,684 $2.2 Million
Q1 2023 May 15, 2023	BUY	$52.6 - $67.34 $181,733 - $232,659	3,455 Added 7.91%	47,158 $2.57 Million
Q4 2022 Feb 13, 2023	BUY	$59.56 - $76.6 $2.01 Million - $2.59 Million	33,758 Added 339.45%	43,703 $2.73 Million
Q3 2022 Nov 14, 2022	BUY	$57.96 - $78.12 $371,813 - $501,139	6,415 Added 181.73%	9,945 $701,000
Q2 2022 Aug 11, 2022	BUY	$39.5 - $64.42 $139,435 - $227,402	3,530 New	3,530 $200,000
Q4 2020 Feb 11, 2021	SELL	$42.19 - $51.5 $335,115 - $409,064	-7,943 Closed	0 $0
Q3 2020 Nov 06, 2020	SELL	$35.33 - $51.04 $246,921 - $356,718	-6,989 Reduced 46.81%	7,943 $405,000
Q2 2020 Aug 07, 2020	BUY	$22.91 - $39.83 $342,092 - $594,741	14,932 New	14,932 $524,000

233

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.